Volume 99, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



is a major cause of severe diarrhea in children less than the age of 5 years in sub-Saharan Africa. The aim of this study was to describe the (sub-)serotype distribution and antimicrobial susceptibility of serogroups from Centrafrican patients with diarrhea between 2002 and 2013. We collected 443 isolates in total. The most common serogroups were ( = 243, 54.9%), followed by ( = 90, 20.3%) and ( = 72, 16.3%). The high diversity of (sub-)serotypes of and may impede the development of an efficient vaccine. Rates of resistance were high for ampicillin, chloramphenicol, tetracycline, and cotrimoxazole but low for many other antimicrobials, confirming recommendations for the use of third-generation cephalosporins (only one organism resistant) and fluoroquinolones (no resistance). However, the detection of one extended-spectrum beta-lactamase–producing organism highlights the need for continued monitoring of antimicrobial drug susceptibility.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Liu L, Oza S, Hogan D, Perin J, Rudan I, Lawn JE, Cousens S, Mathers C, Black RE, , 2015. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 385: 430440. [Google Scholar]
  2. Kotloff KL, 2013. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382: 209222. [Google Scholar]
  3. Breurec S, 2016. Etiology and epidemiology of diarrhea in hospitalized children from low income country: a matched case-control study in Central African Republic. PLoS Negl Trop Dis 10: e0004283. [Google Scholar]
  4. Anderson M, Sansonetti PJ, Marteyn BS, , 2016. Shigella diversity and changing landscape: insights for the twenty-first century. Front Cell Infect Microbiol 6: 45. [Google Scholar]
  5. Livio S, 2014. Shigella isolates from the global enteric multicenter study inform vaccine development. Clin Infect Dis 59: 933941. [Google Scholar]
  6. Bercion R, Njuimo SP, Boudjeka PM, Manirakiza A, , 2008. Distribution and antibiotic susceptibility of Shigella isolates in Bangui, Central African Republic. Trop Med Int Health 13: 468471. [Google Scholar]
  7. Qiu S, 2015. Shift in serotype distribution of Shigella species in China, 2003–2013. Clin Microbiol Infect 21: 252 e5-8. [Google Scholar]
  8. Bangtrakulnonth A, Vieira AR, Lo Fo Wong DM, Pornreongwong S, Pulsrikarn C, Sawanpanyalert P, Hendriksen RS, Aarestrup FM, , 2008. Shigella from humans in Thailand during 1993 to 2006: spatial-time trends in species and serotype distribution. Foodborne Pathog Dis 5: 773784. [Google Scholar]
  9. Langendorf C, Le Hello S, Moumouni A, Gouali M, Mamaty AA, Grais RF, Weill FX, Page AL, , 2015. Enteric bacterial pathogens in children with diarrhea in Niger: diversity and antimicrobial resistance. PLoS One 10: e0120275. [Google Scholar]
  10. Rafai C, Frank T, Manirakiza A, Gaudeuille A, Mbecko JR, Nghario L, Serdouma E, Tekpa B, Garin B, Breurec S, , 2015. Dissemination of IncF-type plasmids in multiresistant CTX-M-15-producing Enterobacteriaceae isolates from surgical-site infections in Bangui, Central African Republic. BMC Microbiol 15: 15. [Google Scholar]
  11. Mao Y, 2013. Changing trends and serotype distribution of Shigella species in Beijing from 1994 to 2010. Gut Pathog 5: 21. [Google Scholar]
  12. Shakya G, Acharya J, Adhikari S, Rijal N, , 2016. Shigellosis in Nepal: 13 years review of nationwide surveillance. J Health Popul Nutr 35: 36. [Google Scholar]
  13. Kahsay AG, Muthupandian S, , 2016. A review on serodiversity and antimicrobial resistance patterns of Shigella species in Africa, Asia and South America, 2001–2014. BMC Res Notes 9: 422. [Google Scholar]
  14. Thompson CN, Duy PT, Baker S, , 2015. The rising dominance of Shigella sonnei: an intercontinental shift in the etiology of bacillary dysentery. PLoS Negl Trop Dis 9: e0003708. [Google Scholar]
  15. Bercion R, Demartin M, Recio C, Massamba PM, Frank T, Escriba JM, Grimont F, Grimont PA, Weill FX, , 2006. Molecular epidemiology of multidrug-resistant Shigella dysenteriae type 1 causing dysentery outbreaks in Central African Republic, 2003–2004. Trans R Soc Trop Med Hyg 100: 11511158. [Google Scholar]
  16. Levine MM, , 2006. Enteric infections and the vaccines to counter them: future directions. Vaccine 24: 38653873. [Google Scholar]
  17. Levine MM, Kotloff KL, Barry EM, Pasetti MF, Sztein MB, , 2007. Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Nat Rev Microbiol 5: 540553. [Google Scholar]
  18. Noriega FR, Liao FM, Maneval DR, Ren S, Formal SB, Levine MM, , 1999. Strategy for cross-protection among Shigella flexneri serotypes. Infect Immun 67: 782788. [Google Scholar]
  19. von Seidlein L, 2006. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med 3: e353. [Google Scholar]
  20. Farzam N, Ramon-Saraf R, Banet-Levi Y, Lerner-Geva L, Ashkenazi S, KublnKielb J, Vinogradov E, Robbins JB, Schneerson R, , 2017. Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice. Vaccine 35: 49904996. [Google Scholar]

Data & Media loading...

  • Received : 23 Nov 2017
  • Accepted : 11 Apr 2018
  • Published online : 25 Jun 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error